Kestra Investment Management LLC acquired a new stake in Atlassian Corporation PLC (NASDAQ:TEAM – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,459 shares of the technology company’s stock, valued at approximately $1,875,000.
Other large investors have also bought and sold shares of the company. Activest Wealth Management raised its position in Atlassian by 372.4% in the third quarter. Activest Wealth Management now owns 137 shares of the technology company’s stock worth $25,000 after acquiring an additional 108 shares in the last quarter. Reyes Financial Architecture Inc. acquired a new stake in Atlassian in the 3rd quarter valued at about $49,000. Fortitude Family Office LLC boosted its position in shares of Atlassian by 23.0% during the 3rd quarter. Fortitude Family Office LLC now owns 289 shares of the technology company’s stock valued at $52,000 after purchasing an additional 54 shares in the last quarter. Physician Wealth Advisors Inc. boosted its position in shares of Atlassian by 142.4% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 337 shares of the technology company’s stock valued at $60,000 after purchasing an additional 198 shares in the last quarter. Finally, Manning & Napier Advisors LLC bought a new position in shares of Atlassian during the 2nd quarter valued at about $27,000. Institutional investors own 94.45% of the company’s stock.
Insider Activity
In related news, CAO Gene Liu sold 337 shares of the company’s stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $210.00, for a total value of $70,770.00. Following the completion of the sale, the chief accounting officer owned 55,531 shares in the company, valued at approximately $11,661,510. This represents a 0.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO James Chuong sold 9,054 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $172.45, for a total transaction of $1,561,362.30. Following the completion of the transaction, the chief financial officer directly owned 279,218 shares of the company’s stock, valued at $48,151,144.10. This represents a 3.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 22,475 shares of company stock worth $3,822,643 over the last 90 days. 37.63% of the stock is owned by company insiders.
Atlassian Trading Down 4.1%
Shares of TEAM opened at $148.60 on Wednesday. The business’s 50-day moving average price is $194.43 and its 200 day moving average price is $119.84. The stock has a market capitalization of $37.62 billion, a P/E ratio of 412.79, a P/E/G ratio of 16.70 and a beta of 1.16. Atlassian Corporation PLC has a 1-year low of $56.01 and a 1-year high of $229.96. The company has a current ratio of 0.72, a quick ratio of 0.78 and a debt-to-equity ratio of 1.09.
Atlassian (NASDAQ:TEAM – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The technology company reported $1.65 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.26. Atlassian had a net margin of 1.28% and a return on equity of 33.53%. The company had revenue of $1.77 billion during the quarter, compared to analyst estimates of $1.71 billion. During the same period in the prior year, the firm earned $1.04 earnings per share. The business’s quarterly revenue was up 23.7% on a year-over-year basis. Analysts expect that Atlassian Corporation PLC will post 0.67 earnings per share for the current year.
Analyst Ratings Changes
A number of analysts recently commented on the stock. TD Cowen boosted their target price on shares of Atlassian from $145.00 to $180.00 and gave the stock a “hold” rating in a report on Tuesday, November 3rd. Truist Financial restated a “buy” rating and set a $200.00 target price (down from $250.00) on shares of Atlassian in a report on Friday, November 6th. Wells Fargo & Company reduced their target price on shares of Atlassian from $270.00 to $200.00 and set an “overweight” rating for the company in a report on Friday, November 6th. Mizuho lifted their price target on shares of Atlassian from $215.00 to $235.00 and gave the stock an “outperform” rating in a research report on Thursday, October 15th. Finally, UBS Group reaffirmed a “buy” rating on shares of Atlassian in a report on Friday. Twenty-four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $209.48.
Check Out Our Latest Stock Report on Atlassian
Trending Headlines about Atlassian
Here are the key news stories impacting Atlassian this week:
- Positive Sentiment: Atlassian beat fiscal first-quarter 2027 estimates for revenue, earnings and cloud growth. Some analysts also maintained positive ratings, including Truist’s reiterated Buy rating; another report said a price target was raised to $190. Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains Truist Reiterates Buy Rating
- Neutral Sentiment: Citigroup lowered its target to $220 from $245 and Barclays cut its target to $210 from $222, but both retained bullish ratings—Buy and Overweight, respectively. Citigroup Ratings Barclays Ratings
- Negative Sentiment: The key concern is guidance: investors reacted to indications of slowing growth, and shares fell sharply after the outlook overshadowed the quarterly beat. Reports also noted price-target reductions from Oppenheimer, Wells Fargo, BTIG and Jefferies, reinforcing a more cautious near-term outlook. Guidance and Analyst Revisions Oppenheimer Target Reduction Wells Fargo Target Reduction
About Atlassian
Atlassian Corporation develops collaboration and productivity software for software, IT and business teams. Its products help organizations plan and track work, manage software development and support services, and share information across teams. Its product portfolio includes Jira for project and issue tracking, Confluence for team documentation and collaboration, Jira Service Management for IT and other service teams, Trello for visual work management, and Bitbucket for code collaboration. Atlassian also offers cloud-based products and tools for distributed teams.
Recommended Stories
- Five stocks we like better than Atlassian
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Want to see what other hedge funds are holding TEAM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atlassian Corporation PLC (NASDAQ:TEAM – Free Report).
Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.
